Evidence map›Paper›PMID 39927073›Full record

ArticleAmerican journal of ophthalmology case reports2025

Two cases of therapeutic scleral lenses for KID syndrome.

Melynda Gagliardi, Bita Asghari

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Scleral lenses and PROSE: indications, complications, and future challenges.Medical hypothesis, discovery & innovation ophthalmology journal · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Melynda GagliardiEyes on Weston, 10-8633 Weston Road, Vaughan, ON, L4L9R6, Canada.
Bita AsghariBostonSight, 464 Hillside Ave, Needham, MA, 02494, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This case series describes the therapeutic application of customized scleral lenses via prosthetic replacement of the ocular surface ecosystem (PROSE) in patients with Keratitis-Ichthyosis-Deafness (KID) syndrome. It proposes PROSE or scleral lens wear as a therapeutic option for KID syndrome. Observations: Two patients with KID syndrome were successfully fitted with PROSE devices, also referred to as prosthetic devices, and continued with wear. The duration of lens wear ranged from one to seven years. One patient was pediatric with severe disease, and the other an adult with milder disease. The pediatric patient had challenges with application and removal and ultimately discontinued device wear; however, demonstrated improvement in corneal surface health through duration of wear for the right eye. The second patient continued with device wear for seven years, with resolution of recurrent corneal erosions, improved comfort and stabilization of corneal surface health. Both patients had benefit with PROSE device wear. Conclusion and importance: Management of ocular surface disease in KID syndrome can be challenging with limited therapeutic options including poor surgical outcomes. This case series supports the therapeutic application of scleral lenses in patients with KID syndrome.

Indexed as

Bandage contact lensIchthyosisKeratitisKID syndromeNeovascularizationPROSEScleral lens

Identifiers

PMID39927073
PMCPMC11804770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.